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Objective: Diet interventions may reduce the risk
of urinary stone formation and its recurrence, but
there is no conclusive consensus in the literature
regarding the effectiveness of dietary interventions and recommenda-
tions about specific diets for patients with urinary calculi. The aim of
this study was to review the studies reporting the effects of different
dietary interventions for the modification of urinary risk factors in
patients with urinary stone disease. 
Materials and Methods: A systematic search of the Pubmed database lit-
erature up to July 1, 2014 for studies on dietary treatment of urinary
risk factors for urinary stone formation was conducted according to a
methodology developed a priori. Studies were screened by titles and
abstracts for eligibility. Data were extracted using a standardized form
and the quality of evidence was assessed. 
Results: Evidence from the selected studies were used to form evidence-
based guideline statements. In the absence of sufficient evidence, addi-
tional statements were developed as expert opinions. 
Conclusions: General measures: Each patient with nephrolithiasis
should undertake appropriate evaluation according to the knowledge of
the calculus composition. Regardless of the underlying cause of the stone
disease, a mainstay of conservative management is the forced increase
in fluid intake to achieve a daily urine output of 2 liters. 
Hypercalciuria: Dietary calcium restriction is not recommended for
stone formers with nephrolithiasis. Diets with a calcium content ≥ 1
g/day (and low protein-low sodium) could be protective against the risk
of stone formation in hypercalciuric stone forming adults. Moderate
dietary salt restriction is useful in limiting urinary calcium excretion
and thus may be helpful for primary and secondary prevention of
nephrolithiasis. A low-normal protein intake decrease calciuria and
could be useful in stone prevention and preservation of bone mass.
Omega-3 fatty acids and bran of different origin decreases calciuria, but
their impact on the urinary stone risk profile is uncertain. Sports bever-
age do not affect the urinary stone risk profile. Hyperoxaluria: A diet
low in oxalate and/or a calcium intake normal to high (800-1200
mg/day for adults) reduce the urinary excretion of oxalate, conversely a
diet rich in oxalates and/or a diet low in calcium increase urinary
oxalate. A restriction in protein intake may reduce the urinary excre-
tion of oxalate although a vegetarian diet may lead to an increase in
urinary oxalate. Adding bran to a diet low in oxalate cancels its effect of
reducing urinary oxalate. Conversely, the addition of supplements of
fruit and vegetables to a mixed diet does not involve an increased excre-
tion of oxalate in the urine. The intake of pyridoxine reduces the excre-
tion of oxalate. Hyperuricosuria: In patients with renal calcium stones
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the decrease of the urinary excretion of uric acid after restriction of
dietary protein and purine is suggested although not clearly demonstrat-
ed. Hypocitraturia: The administration of alkaline-citrates salts is rec-
ommended for the medical treatment of renal stone-formers with hypoc-
itraturia, although compliance to this treatment is limited by gastroin-
testinal side effects and costs. Increased intake of fruit and vegetables
(excluding those with high oxalate content) increases citrate excretion
and involves a significant protection against the risk of stone formation.
Citrus (lemons, oranges, grapefruit, and lime) and non citrus fruits
(melon) are natural sources of dietary citrate, and several studies have
shown the potential of these fruits and/or their juices in raising urine
citrate levels. Children: There are enought basis to advice an adequate
fluid intake also in children. Moderate dietary salt restriction and imple-
mentation of potassium intake are useful in limiting urinary calcium
excretion whereas dietary calcium restriction is not recommended for
children with nephrolithiasis. It seems reasonable to advice a balanced
consumption of fruit and vegetables and a low consumption of chocolate
and cola according to general nutritional guidelines, although no studies
have assessed in pediatric stone formers the effect of fruit and vegeta-
bles supplementation on urinary citrate and the effects of chocolate and
cola restriction on urinary oxalate in pediatric stone formers. 
Despite the low level of scientific evidence, a low-protein (< 20 g/day)
low-salt (< 2 g/day) diet with high hydration (> 3 liters/day) is strongly
advised in children with cystinuria. Elderly: In older patients dietary
counseling for renal stone prevention has to consider some particular
aspects of aging. A restriction of sodium intake in association with a
higher intake of potassium, magnesium and citrate is advisable in order
to reduce urinary risk factors for stone formation but also to prevent the
loss of bone mass and the incidence of hypertension, although more
hemodynamic sensitivity to sodium intake and decreased renal function
of the elderly have to be considered. A diet rich in calcium (1200
mg/day) is useful to maintain skeletal wellness and to prevent kidney
stones although an higher supplementation could involve an increase of
risk for both the formation of kidney stones and cardiovascular diseases.
A lower content of animal protein in association to an higher intake of
plant products decrease the acid load and the excretion of uric acid has
no particular contraindications in the elderly patients, although overall
nutritional status has to be preserved.
KEY WORDS: Urinary calculi; Dietary treatment; Urinary risk
 factors; Hypercalciuria; Hyperoxaluria; Hypocitraturia; Children;
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INTRODUCTION
(Domenico Prezioso, Pasquale Strazzullo, 
Domenico Rendina, Ester Iliano)
Nephrolithiasis (NL) affects 5-15% of the population
worldwide with a recurrence rate higher than 50%. It does
not spare any geographical, cultural, or racial group. An
increase in NL incidence and prevalence has been
observed in the final quarter of the last century in both
genders (1, 2). Approximately 80% of all kidney stones are
composed of calcium salts, namely calcium-oxalate
(CaOx) and calcium phosphate (CaP) (3). The tendency to
form CaOx stones is directly related to urinary concentra-
tions of calcium, oxalate and urate, and inversely associat-
ed with those of magnesium and citrate. In addition to
these metabolic risk factors, also the urinary concentra-
tions of phosphate and hydrogen ions (pH) plays a role in
the pathogenesis of CaP stones (3, 4). A significant per-
centage of the remaining stones is composed of uric acid
(UA), which accounts for over 10% of all kidney stones.
UA stones form in the presence of an abnormally low
urine pH (4). Recent epidemiological data indicate that NL
is a significant risk factor for chronic and end stage kidney
disease (5-6).Both environmental and genetic factors syn-
ergistically contribute to the pathogenesis of the different
types of stones (2-4). The role of inheritance is obvious in
monogenic diseases such as cystinuria, Dent’s disease and
primary hyperoxaluria (4), but also “idiopathic” stone for-
mation show a familial tendency (7). Among environmen-
tal factors, dietary habits appear to play an important role
in the pathogenesis of NL and are likely responsible for its
growing incidence in the last few decades (8-9). Indeed,
NL is considered a systemic disorder associated with a
group of cardio-metabolic conditions such as obesity, dia-
betes, hypertension, metabolic syndrome and coronary
artery disease (10-13), all of them in turn related to nutri-
tional inadequacies. The NL- directly related costs exceed
5 billion dollars each year in the United States. Thus, the
development of (scientifically sound) dietary recommen-
dations for primary and secondary NL prevention should
be seen as one of the most promising cost-saving actions
in the clinical management of NL (5).
Patient evaluation
Each patient with NL should undertake appropriate mor-
pho-functional evaluation (3, 7, 14, 15). The classification
of NL is based on the composition of renal calculi because
the different types of stones present different etiologies
and pathogeneses that require a different therapeutic
approach. Based on the clinical history of the disease, it is
also important to distinguish relapsing forms, from those
associated with metabolic syndrome (MS) and those at
particularly risk of systemic complications such as chron-
ic kidney disease (CKD) and metabolic bone disease
(MBD). Relapsing NL is diagnosed if the patient experi-
enced ≥ 3 new episodes of kidney stones in the past 5
years, although even a patient with first-episode, showing
more calculi in one or both kidneys, should be classified
as a relapsing patient. The general practitioner (GP) is the
professional figure most often involved in the initial diag-
nostic evaluation of the patient. Indeed, a well conducted
history and a limited number of step one laboratory tests
allow to identify several secondary forms of NL and to
select patients with MS and those at increased risk of CKD
or MBD. The medical history will provide information on
i) degree of disease activity over the past 5 years, ii) famil-
iarity of the disease, iii) dietary habits and lifestyle.
Although a comprehensive nutrition survey must be
attended by skilled personnel and requires the use of ded-
icated software, the formulation of a few questions may
provide in most cases enought information about the lith-
ogenic risk associated with the patient’s dietary habits.
Information should be obtained about average caloric
intake, amount and type of ingested liquids and the habit-
ual intake of salt, animal protein, carbohydrates, potassi-
um, calcium and oxalate-rich foods.
Step 1 metabolic investigation includes: blood tests (creati-
nine, urea, glucose, uric acid, Na, K, Cl, calcium, phos-
phorus, lipid profile); urine tests (complete urinalysis and
urine culture for common germs); ultrasound abdomen
examination; analysis of stone composition. This step
thanks to execution simplicity and low costs, may be
applied on almost all NL patients and allows one to select
patients requiring more advanced step two assessment.
Step 2 evaluation may more often require collaboration
with a specialist. It will include again: blood tests (parathy-
roid hormone (PTH), 25 and possibly 1,25 vitamin D,
magnesium, alkaline phosphatase); 24 hour urine collec-
tion for creatinine, urate, sodium, potassium, chloride,
calcium, phosphate, magnesium, citrate, pH, sulphate and
ammonium. The 24 hour urine analysis should be repeat-
ed annually to assess the patients adherence to treatment.
In the case of calcium NL a bone mineral density assess-
ment by DEXA may be of value. Diagnostic Imaging
workup is based on: abdomen X-ray and ultrasonograph-
ic examination, which in combination allow to recognize
90% of cases of NL; echo-color-Doppler examination with
measurement of the resistance index to detect urine flow
obstruction; urography, currently used only before surgi-
cal treatment, endoscopy and lithotripsy or in other par-
ticular circumstances; non contrast computed tomogra-
phy (NC CT, used for diagnostic emergency in patients
with renal colic, allowing detection of all types of calculi
or their indirect signs; Uro CT, which consists in a normal
CT scan of the abdomen exploiting the early stage of
impregnation for the study of the kidneys and the blad-
der; ascending or descending pielography, to be per-
formed only in the context of operating procedures, e.g.
ureterorenoscopy; sequential renal scintiscan, that is still
the most reliable method for the assessment of impairment
of individual renal unit and degree of obstruction, if pres-
ent; magnetic resonance imaging (MRI) to be preferred
whenever the radiation burden involved with other proce-
dures is of concern (e.g. pregnant and pediatric patients).
Stone analysis
There are two main categories of urinary stones: calcium
stones and no-calcium stones, which are both the conse-
quence of crystallization and aggregation of highly concen-
trated urinary components. Although stone composition
analysis is not always feasible or achievable, there is help-
ful information from such an investigation that can aid for
prevention of recurrences. For instance, as shown by a well
performed randomized controlled trial (16), calcium phos-
phate or brushite stones may be associated to primary
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hyperparathyroidism (HPT) and renal tubular acidosis
(RTA), calcium oxalate stones may be associated to chron-
ic diarrhoea, acid uric stones to gouty diathesis, struvite
stones to urinary infection and cystine stones to urinary
cystine excretion. These associations are particularly evi-
dent in the case of non-calcium stones, as also shown by
Kourambas et al. (17), who found that patients with no-cal-
cium stones were found to have specific metabolic disor-
ders according to the type of analysed calculi, whereas
patients with calcium stones were more heterogeneous
with regard to concomitant metabolic disorders. 
Knowledge of the calculus composition may help the
physician to prescribe of the most appropriate diagnostic
workup and with the implementation of adequate dietary
and therapeutic measures (18). Namely, should the urine
be alkalinized? Will the stone be amenable to extracorpo-
real shock wave lithotripsy or should ureteroscopy or per-
cutaneous lithotripsy be attempted? Stone composition
analysis should be performed in all first-time stone formers
and repeat stone analysis is needed in case of recurrence
under pharmacological prevention, early recurrence after
interventional therapy with complete stone clearance, late
recurrence after a prolonged stone-free period (19).
The methods currently available for the of stone composi-
tion analysis are: i) chemical analysis (now deemed obso-
lete because of its major limitations), thermogravimetry,
emission spectroscopy, polarizing spectroscopy, X-ray dif-
fraction, X-ray coherent scatter/crystallography, scanning
electron microscopy, and infrared spectroscopy (20). The
ones preferred are infrared spectroscopy and X-ray diffrac-
tion (21-23). X-ray diffraction uses monochromatic X-rays
for identifying the constituents of a renal stone based on
the unique diffraction patterns produced by a crystalline
material (24). Infrared (IR) spectroscopy uses IR radiation
in order to cause atomic vibrations energy absorption and
final appearance of absorption bands in the IR spectrum of
stone samples 24). Equivalent results can be obtained by
polarisation microscopy, based on the interaction of polar-
ized light with stone crystals, which however is limited to
centers with special expertise (25). In addition to the
above mentioned commonly used techniques, there are
other techniques which may unravel more detailed infor-
mation on the molecular structure of the stone nuclear
region (26). These techniques are not used in routine diag-
nostic laboratories for being costly and requiring special
expertise or sample preparation. Studies involving the use
of single-energy CT technology have shown that valuable
information about stone composition may be gained,
enabling differentiation between uric acid and calcium
stones on the basis of their different attenuations (27).
Dual-energy CT by low and high-energy scanning is capa-
ble to differentiate various materials with similar electron
densities but different photon absorption (27), thus con-
tributing to the chemical characterization of stones for the
purpose of surgical or medical treatment decision. 
Water intake
For all NL patients, regardless of the underlying cause of
the stone disease, a mainstay of conservative management
is to force the increase in fluid intake to achieve a daily
urine output of 2 litres (28). Theoretically, increased urine
output may have two effects. First, the ensuing mechanical
diuresis may prevent urine stagnation and formation of
symptomatic stones. More important, the dilute urine
alters the supersaturation of stone components. 
Modification of the concentration of lithogenic factors is
indeed the focus of stone prevention. The effect of urinary
dilution on crystallization of stone-forming salts was first
evaluated by Pak et al. (2), who showed that an increased
fluid intake and the subsequent urine dilution had a pro-
tective effect on the crystallization of calcium salts (29).
Currently, no evidence is available with regard to the actu-
al benefit of increasing water intake for primary prevention
of urinary stones, however there is a randomised con-
trolled trial evidence of benefit from increasing water
intake for the prevention of stone recurrences (30). In the
trial by Borghi and co-workers, participants randomized to
> 2 l/d of water intake were significantly less likely to have
stone recurrence over 5 years and a much longer time to
recurrence compared with the untreated control group
(30). In another study by Sarica et al. on NL patients who 
underwent shockwave lithotripsy and were currently
stone-free, those randomized to increased fluid intake to
achieve a urine output of > 2.5 l/d for 2-3 years had a stone
recurrence rate of 8% compared with 56% of those allo-
cated to no treatment (31). A study by Frank et al. com-
pared the incidence of urinary stones in two desert towns
after an educational program had been run in one of them
for increasing water intake as a preventive measure against
the risk of NL. Upon a 3-yr follow-up, the prevalence of
urinary stones was significantly lower in the intervention
town (0.28% versus 0.85%) (32). Similar findings have
been provided by a long-term study in the US (33). 
It has long been debated whether differences in drinking
water characteristics, namely water hardness, fixed residue
and saline components may impact on the risk of renal
stones. Whereas Coen et al. reported that an increase in
water hardness resulted in higher incidence of NL (34), in
most other studies greater water hardness, i.e, mineral
content, has been associated with beneficial effects in pre-
venting stone events, probably through different mecha-
nisms, including the increase in urinary citrate (35-38).
Confounding factors may explain the discrepancies in
results. Karagülle et al., found that bicarbonate-rich miner-
al water had a positive effect on calcium oxalate urine
supersaturation (38), probably due to increased pH (in a
range opposing calcium oxalate stone formation) and to
greater concentration of the inhibitory factors citrate and
magnesium. This finding was confirmed in the study by
Bertaccini et al. who showed that the intake of a water with
medium mineral (calcium 119.7 mg/l) and high bicarbon-
ate (412 mg/l) content causes specific changes of urinary
composition that could be beneficial to prevent stone for-
mation (39), the bicarbonate load increasing urinary pH
and urinary citrate excretion. The latter can indeed be
helpful for prevention of both uric acid lithiasis, thanks
to the higher urinary pH with increased solubility of
uric acid, and calcium lithiasis, as a consequence of the
increased urinary citrate concentration, with inhibition of
calcium crystal formation and aggregation. The higher
potassium content of mineral water also promoted urinary
alkalization and led to further increase in urinary citrate
excretion (39). According to Siener et al. also the magne-
sium content of mineral water results in favourable
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changes in urine composition, namely a higher urinary
magnesium concentration (40).
MATERIALS AND METHODS
The CLU working group conducted a systematic search of
the Pubmed database literature up to July 1, 2014 for
studies on dietary treatment of urinary risk factors for uri-
nary stone formation.Reviewers were divided in 5 groups
for searching about dietary intervention for treatment of
hypercalciuria (group 1), hyperoxaluria and hyperurico-
suria (group 2), hypocitraturia (group 3) and about
dietary prevention of urinary calculi in the child (group 4)
and in the elderly (group 5). Search terms were reported
in Table 1. According to a methodology developed a pri-
ori meta-analyses, randomized controlled trials, case con-
trol and cohort studies were included. Review studies and
case reports were excluded. Additional articles were iden-
tified from reference lists of relevant articles or, if neces-
sary, by other more specific search strategies. Three or
more reviewers for each group independently screened
titles and abstracts of studies for potential eligibility. The
quality of evidence was assessed using the Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) framework. The reviewers extracted
data using a standardized form. The following data were
abstracted: type of study, characteristics of trial partici-
pants (number, gender, healthy/RSFs); type of interven-
tion; outcomes and quality of evidence. 
RESULTS
Summary of findings tables were built for defined out-
comes (posted in Supplementary Materials on www.aiua.it).
Results of the selected studies were used to form evidence-
based guideline statements. In the absence of sufficient
evidence, additional statements were developed as expert
opinions. 
DISCUSSION AND CONCLUSIONS
Dietary treatment of hypercalciuria
(Marco Rosa, Giovanni Gambaro, P. Manuel Ferraro,
Giampaolo Bianchi, Domenico Rendina, Andrea Tasca)
Generally speaking available literature is of very low qual-
ity data. Quite few randomized clinical trials (RCTs) have
been done, most of them with significant methodological
limitations. They are addressed in depth by a recent
Cochrane review (1) which concluded that “…no com-
pelling evidence was identified to support the use of dietary
interventions to reduce the risk of complications [essentially the
effect on stone rate or on the urinary stone risk profile] among
people with idiopathic hypercalciuria….” also noticing that
“…Overall, the quality of the evidence supporting dietary
interventions is poor…”. The Cochrane review considered 5
RCT; however, in the present systematic review of the lit-
erature we decided not to consider 2 of them because the
dietary intervention was indeed a “pharmacological” treat-
ment with the herbal extract Phyllantus niruri (2) or
because the total intake of calcium was not controlled (3). 
However, a number of observational or non-controlled
interventional studies, either retrospective or prospective
on urinary stone risk-factors (mainly variations in calciuria
and/or oxaluria) can be retrieved. We obtained from spe-
cialized registers 374 articles of which 26 have been con-
sidered in the present statement. 
1. Dietary calcium restriction is not recommended for stone
formers with nephrolithiasis. Diets with a calcium content ≥ 1
g/day (and low protein-low sodium) could be protective
against the risk of stone formation in hypercalciuric stone
forming adults. 
A cross-sectional study in stone formers has shown that
higher calcium intakes at levels typically observed in free-
living individuals are associated with only small increases
in calciuria (3). A previous observational cohort prospec-
tive study in healthy men had disclosed that a high dietary
calcium intake decreases the risk of symptomatic kidney
stones (4). A retrospective, uncontrolled longitudinal
study (very low quality data) on the effect of a calcium
restricted diet in hypercalciuric and normocalciuric stone
formers concluded that secondary rise in urinary oxalate
occurring from calcium restriction can be avoided by con-
current dietary oxalate restriction; the effect on urinary
saturation of calcium oxalate was modest (6). Another
uncontrolled longitudinal study (retrospective of very low
quality) in hypercalciuric stone formers reported that low
calcium diet only marginally decrease calciuria and did
not modify fasting hypercalciuria (7). In an uncontrolled
descriptive study, in 50% of patients who were hypercal-
ciuric on a free diet, when assuming a 1000 mg/d calcium
diet (higher content than in the free diet) calcium excre-
tion fell markedly or normalized (8). An uncontrolled lon-
gitudinal, prospective study has shown that, on a low-cal-
cium diet, absorptive hypercalciuric patients are particu-
larly prone to develop hyperoxaluria (9).
In an observational cohort study (prospective) oxaluria
Group Search terms Papers n° Selected Added
1 (urinary calculi OR kidney stones OR renal stones OR nephrolithiasis OR urolithiasis) AND diet AND hypercalciuria 374 26 0
2 (urinary calculi OR kidney stones OR renal stones OR nephrolithiasis OR urolithiasis) AND diet AND hyperoxaluria 183 37 3
(urinary calculi OR kidney stones OR renal stones OR nephrolithiasis OR urolithiasis) AND diet AND hyperuricosuria 75 6 0
3 (urinary calculi OR kidney stones OR renal stones OR nephrolithiasis OR urolithiasis) AND diet AND hypocitraturia 54 5 19
4 (urinary calculi OR kidney stones OR renal stones OR nephrolithiasis OR urolithiasis) AND diet AND children 197 38 0
5 (urinary calculi OR kidney stones OR renal stones OR nephrolithiasis OR urolithiasis) AND diet AND elderly 597 3 19
Table 1. Search Pubmed terms.
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was significantly reduced after one week treatment with
calcium 1 g/day in stone formers who were usually on a
regular low calcium diet (< 500 mg/day) but not in those
with diet-dependent hypercalciuria (10). With a similar
experimental design in hypercalciuric stone patients, the
same group did not show a significant additional increase
in urinary calcium (11). In an uncontrolled longitudinal
prospective study in hypercalciuric idiopathic stone form-
ers an intake of a high-calcium diet for 5-6 days reduced
urinary oxalate and the probability of being a stone former
according to PSF index (12). In a 4 weeks randomized
controlled trial (RCT) in absorptive hypercalciuric stone
formers, a low calcium (< 500 mg/day), normal protein
and salt diet did not significantly modify the urine risk
profile for stone formation while possibly inducing an
increased bone turn-over (13). In an uncontrolled longi-
tudinal 4-week prospective study in calcium stone form-
ers a low calcium diet (440 mg/day) decreased calciuria
but increased the urine supersaturation for calcium-
oxalate also in hypercalciuric patients (14). In an uncon-
trolled longitudinal prospective study on idiopathic
hypercalciuria, a combined low calcium, low oxalate diet
did not significantly decreased the PSF (15). A RCT has
shown that in hypercalciuric stone formers with a 2-3
L/day water intake, a diet with calcium 1200 mg/day,
together with reduced protein (less than 15% caloric
intake) and salt (< 50 mmol/day) was superior in reducing
stone recurrences versus a 400 mg/day low calcium diet
(16). In this study, however, it is difficult to dissect the
preventive role of the different components of the diets
(normal calcium versus low protein versus low salt).
Furthermore, it is difficult to understand if the positive
results were due to the favourable effects of this latter diet
alone, or the results were magnified by a particularly
unfavourable diet as the low-calcium diet.
2. Moderate dietary salt restriction is useful in limiting urinary
calcium excretion and thus may be helpful for primary and
secondary prevention of nephrolithiasis. 
A RCT trial in hypercalciuric stone formers with high
baseline sodium intake, a low-salt (< 60 mmol/d sodium,
or < 3.5 g/d NaCl) normocalcic (800-1000 mg/d) diet
reduced calcium excretion (17).
3. A low-normal protein intake decreases calciuria and could be
useful in stone prevention and preservation of bone mass.
In a short term uncontrolled longitudinal prospective
study on a small cohort of hypercalciuric stone formers a
diet with an intake of 0.8 g of protein per Kg of body
weight and normal calcium intake decreased calciuria and
a number of bone and stone risk factors possibly because
of a reduced acid load (18). This observation is in keeping
with the study by Borghi at al. (16) and with a number of
observations in healthy non-stone forming people.
4. Omega-3 fatty acids decrease calciuria, but the impact on
the urinary stone risk profile is uncertain. 
Although an observational cohort study of moderate qual-
ity disclosed in healthy non-stone forming people that
greater levels of arachidonic and linoleic acid intake do
not increase the risk for developing a kidney stone, and
greater intake of Omega-3 fatty acids does not reduce the
risk (based on a food frequency questionnaire) (19), very
low quality data may suggest that the administration
Omega-3 fatty acids of fish oli alone or combined with
empiric dietary counseling decrease urinary calcium in
hypercalciuric stone formers (20-22). However, the
impact of Omega-3 administration on the risk profile for
recurrent nephrolithiasis may be limited (20).
5. Bran of different origin decreases calciuria, but the impact
on the urinary stone risk profile is uncertain.
In a descriptive study on idiopathic hypercalciuric
patients, rice bran (10 g twice daily) for 1 month to 3 years
decreased calciuria (23). In a very small uncontrolled lon-
gitudinal, prospective study Farmolith (a granular powder
consisting of different dietary fibres) decreased calciuria
and oxaluria in absorptive hypercalciuric stone patients
(24). Wheat bran (14 g) assumed in each of the 2 main
meals in stone formers with absorptive hypercalciuria
decreased calciuria without changing oxaluria in a small
uncontrolled longitudinal 90 days study (25). In a small
RCT on hypercalciuric stone formers, 30 g of dietary fiber
as unprocessed wheat bran in association with a low calci-
um-low oxalate diet induced a 23.5% decrease in calciuria
in comparison with only a 5.6% reduction obtained with
diet alone; however, oxaluria was decreased 21.4% by diet
alone compared with only 3.9 % in the diet and fiber treat-
ment group (26).
6. Sports beverage do not affect the urinary stone risk profile.
Carbohydrate-electrolyte sports beverages (Gatorade) in a
prospective crossover study on healthy and stone forming
patients had no effect on urinary calcium or other urine
stone risk parameters (27).
Dietary treatment of hyperoxaluria (Martino Marangella, 
Fabrizio Travaglini, Alberto Trinchieri)
Dietary oxalate and its precursors 
1. In human experiments, the intestinal absorption of
oxalate is greater on a diet high in oxalate (600 mg) com-
pared to that on a diet poor in oxalate (63 mg), although
there is an adaptation with lower rate of absorption if the
diet with a high content of oxalate continues for over 6
weeks (Zimmermann 2005 experimental controlled study
M) (1).
2.. A diet rich in oxalate causes a significant increase in
urinary oxalate levels (Butz 1980 - experimental study M,
Massey 1993- experimental study M, Siener 2003 - observa-
tional study L, de O G Mendonça 2003 - RCT M) (2-5).
3. A diet low in oxalate is effective in reducing urinary
excretion of oxalate and urinary saturation for calcium
oxalate with respect to a basal free choice diet (Kirac 2013
Experimental non controlled - M; Laminski 1991 experimen-
tal non controlled - M) (6, 7).
4. In patients with idiopathic calculi an intake of ascorbic
acid > 1 g/day is more frequent than in controls (Griffith
1986 case-control observational study - L) (8). A load of
ascorbic acid may lead to an increase in serum and urinary
levels of oxalate by increasing the intestinal absorption and
endogenous synthesis. In total parenteral nutrition (TPN)
an increase of ascorbic acid infusion from 100 to 200 mg
induces an increase of oxaluria of about 0.10 mmol/day.
(Pena de la Vega, 2004 experimental study M) (9). 
5. The increase of oxaluria after oral ingestion of large
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amounts of ascorbic acid is not well predictable and has
not been confirmed unanimously but it was suggested that
patients at risk of kidney stones should not exceed an
intake of 500 mg/day (Butz 1980, Massey 2005 M experi-
mental studies M) (2, 10).
Dietary calcium (and magnesium)
6. Epidemiological studies have shown that the excretion
of oxalate is inversely related to dietary intake of magne-
sium (Eisner 2012 - observational cohort study L) (11) and
calcium (Trinchieri 1998 observational cohort study L) (12).
7. The rate of intestinal absorption of oxalate, evaluated
with [ 13C2] oxalate in healthy volunteers on a diet con-
taining 800 mg of calcium, ranges between 2.2 and
18.5%. The intra-individual variation is wide (3.4 ± 1.7%)
(von Unruh, 2003 - experimental study M) (13).
8. The intestinal absorption of radioactive [13C2] oxalate in
a diet containing 1200 mg of calcium (diet + supplements
of calcium citrate and calcium carbonate) is 2%, but it
increases to 17% at 200 mg of dietary calcium. The
increase is linear with the decrease of dietary calcium, but
there is no further reduction of intestinal absorption of
oxalate when dietary calcium increases > 1200 mg (Von
Unruh, 2004 - experimental study M) (14). 
9. In healthy subjects and calcium renal stone formers a
low-calcium diet causes a significant decrease in the lev-
els of urinary calcium but increases urinary excretion of
oxalate and the risk of renal stone formation (Bataille
1983 - experimental non controlled study M) (15).
10. In idiopathic renal calcium stone formers with hyper-
calciuria a low calcium diet increases urinary oxalate
excretion more than in normocalciuric. On low calcium
diet urinary oxalate excretion is related to the degree of
intestinal absorption of calcium (Jaeger 1985 - experimen-
tal non controlled M) (16).
11. In renal stone formers with idiopathic hypercalciuria a
high-calcium diet (900-1070 mg/day) decreases the excre-
tion of oxalate, the oxalate/creatinine ratio and the litho-
genic risk in comparison with a normal-calcium diet (700
mg/day) (Brown 1987 experimental non controlled study - L,
Nakada 1988 experimental non controlled study - M) (17, 18). 
12. In calcium oxalate renal stone patients with hyperox-
aluria the addition of supplements of calcium citrate to the
low-oxalate diet did not result in a greater decrease of uri-
nary excretion of oxalate than diet alone, although the
supersaturation for calcium oxalate decreases more signifi-
cantly (Penniston, 2009 experimental non controlled M) (19).
Vegetarian
13. Vegetarians have higher urinary oxalate levels than
controls on a free-choice mixed mediterranean diet with
significantly higher calcium/oxalate ratio resulting from an
higher intake of oxalate and increased fractional intestinal
absorption of oxalate (Marangella 1989 - observational study
L) (20). 
14. In vegetarians the risk of calcium oxalate crystallization
is not decreased (increase in urinary pH, citrate and mag-
nesium excretion and decline in calcium excretion, but
increase in urinary oxalate by 30%) (Siener R, 2002 - exper-
imental non controlled study M) (21).
Fruit and vegetables
15. In patients with hyperoxaluria (> 40 mg), the diet rich
in fruits, vegetables, whole grains and low-fat dairy prod-
ucts and low in total fat and saturated fat, cholesterol,
refined carbohydrates and sweets and meat, which is rec-
ommended for patients with hypertension (Dietary
Approaches to Stop Hypertension - DASH) results in a slight
increase in urinary excretion of oxalate compared with a
diet low in oxalates, but decreases the supersaturation
with respect to calcium oxalate due to the concomitant
increase in excretion of magnesium and citrate and
increase of urinary pH (Noori 2014 - RCT H) (22). 
16. In normal healthy subjects the abolition of fruits and
vegetables induces a slight increase of calcium oxalate and
calcium phosphate saturation as it reduces excretion of cit-
rate, magnesium, potassium and also oxalate, while
increasing urinary excretion of calcium and ammonium.
In hypocitraturic calcium renal stone formers, adding
fruits and vegetables increases excretion of magnesium
and citrate, urinary pH and urinary volume, without
changing excretion of oxalate and calcium. The result is a
significant reduction of lithogenic risk for calcium salts
and for uric acid (Meschi 2004 - experimental non controlled
study M) (23). 
Protein
17. A moderate load of glycine (4.5 g daily) or protein (50
g daily, 50% animal protein) has no effect on serum or uri-
nary oxalate (Butz 1980 - experimental non controlled study
M) (2).
18. A diet very rich in meat (700 g of meat or fish daily,
2.26 g of protein/kg daily) increases urinary oxalate in
approximately one third of patients with calcium
nephrolithiasis, with an average increase of 73 μmol/24 h
whereas no change is observed in normal subjects. Patients
with mild hyperoxaluria have a more substantial increase
of urinary oxalate (+100 μmoli). The mechanism of sensi-
tivity is not clear, but does not involve deficit in vitamin B6
(Nguyen 2001 - experimental non controlled study M) (24). 
19. The effect of a reduction in dietary protein on urinary
excretion of oxalate is controversial. Changing calcium
stone-formers from a high to a low animal protein intake
causes no variation in urinary oxalate (Marangella 1989
observational study L) (20). In renal stone formers with
idiopathic hypercalciuria a moderate restriction of protein
intake causes a reduction of urinary calcium, urate and
oxalate and improves the profile of lithogenic patients
(Giannini 1999 experimental non controlled study M) (25). A
diet with reduced intake of protein (< 93 g) and salt (50
mmol) results in a significant reduction of urinary oxalate
excretion and calcium oxalate product (Borghi et al. 2002
RCT H) (26). In patients with idiopathic calcium oxalate
nephrolithiasis and mild hyperoxaluria (> 40 mg/day), a
diet low in protein and salt with normalized calcium
intake for the duration of three months proved to be more
effective in reducing oxaluria in comparison with a diet
low in oxalate administered to a historical control group of
hyperoxaluric patients (Nouvenne et al. 2009 observational
study L) (27). 
Wheat bran
20. In hypercalciuric renal stone formers the addition of 30
g of dietary fiber as unprocessed wheat bran to a low-calci-
um and low-oxalate diet results in a 23.5% decrease of uri-
nary calcium with respect to the 5.6% decrease obtained
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with the diet alone whereas the addition of fiber results in
a 3.9% decrease of urinary oxalate compared to the 21.4%
on diet alone (Gleeson 1990 - experimental study - M) (28).
Pyridoxine
21. The administration of pyridoxine in oral doses of 250-
500 mg daily to both normo- or hyperoxaluric calcium
renal stone formers decreases urinary oxalate excretion
(Nakada 1988 - experimental study - M, Mitwalli 1988 exper-
imental non controlled study M, Ortiz-Alvarado 2010 - exper-
imental non controlled study M) (18, 29, 30).
Probiotics (Lactobacilli)
22. The administration of lactobacilli has not proved to be
effective in reducing the levels of urinary excretion of
oxalate in renal calcium stone patients with idiopathic
hyperoxaluria and calcium (> 40 mg/day) (Goldfarb 2007,
Lieske 2010 - randomized controlled studies H) (31, 32), in
healthy subjects consuming an high-oxalate diet (Siener
2013 - experimental non controlled study M) (33) and in
renal stone formers without hyperoxaluria on a diet rich in
oxalate (Ferraz 2009 experimental non controlled M) (34).
General measures
23. Hyperoxaluric patients shows higher lipid intake and
lower glucidic and calcium intake (Mahe 1993 observation-
al study VL) (35). Dietary counseling according to
Recommended Dietary Allowance results in a reduction of
intakes of total protein, animal protein, fat, and carbohy-
drates and it is associated to a reduction of the excretion
of oxalate. (Nomura 1995 - observational study VL) (36).
The effect of general dietary measures (balanced diet, spe-
cific diet) on urinary oxalate has not always proven effec-
tive in reducing urinary oxalate (Kocvara 1999 - controlled
study L, Siener 2005 - experimental non randomized M;
Schwen 2013 observational study L) (37-39). The dietary
approach is particularly recommended after ESWL
because it induces an increase of urinary oxalate and cal-
cium (Oehlschläger 2003 - observational study L) (40).
Dietary treatment of hyperuricosuria
(Martino Marangella, Fabrizio Travaglini, Alberto Trinchieri)
Protein and purine 
1. In patients with renal calcium stones the decrease of the
urinary excretion of uric acid after restriction of dietary
protein and purine is not well demonstrated. In patients
with hyperuricosuria on free diet, the reduction of dietary
purine normalized the excretion of uric acid in approxi-
mately 45% of cases (Mateos Anton 1984 - Experimental non
controled study L) (1). Complex dietary intervention that
included a reduction in protein and purine, such as a diet
tailored on metabolic risk factors and a diet based on
reduction of animal protein intake (56-64 g/day) and
foods high in purine (75 mg/day) in combination with an
increased intake of fruits, vegetables and cereal grains
(including ¼ cup of bran per day) have not achieved vari-
ations of the excretion of uric acid (Kocvara 1999 RCT L,
Hiatt 1996 RCT H) (2,3), conversely a standardized bal-
anced diet decreased the excretion of uric acid in others
(Siener 2005, experimental study M) (4).
2. A standardized artificial diet (Ensure) in an amount
adjusted for the individual caloric needs is not associated
with higher levels of uric acid excretion in patients with
calcium stones compared with controls (Pais 2007 - exper-
imental study M) (5).
Sodium intake
3. A diet with a high sodium intake (240 mEq.di sodium
for 10 days) to cause an expansion of chronic volume
compared to a diet with a low sodium content (10 mEq.di
sodium for 10 days) results in increased clearance of acid
uric acid, decreased serum uric acid and unchanged uric
acid excretion (Breslau and Pak 1984 observational study of
good quality M) (6). 
Dietary treatment of hypocitraturia
(Renata Caudarella, Andrea Guttilla, Sebastiano Spatafora)
Introduction
Hypocitraturia is common metabolic alteration in kidney
stone-formers with a prevalence ranging from 20 to 60%;
hypocitraturia may be found alone or associated with
other metabolic alterations promoting stone formation. 
The acid-base status of the patient significantly modulates
renal citrate excretion with systemic acidosis promoting
citrate absorption in the proximal renal tubule with its
subsequent incorporation into the Krebs cycle (1).
Instead, alkalosis induces a decrease in citrate absorption,
resulting in increased urinary citrate excretion. Conditions
associated with a lower value of intracellular and urinary
pH, such as metabolic acidosis or hypokalemia, cause a
decrease in citrate excretion in urine (2).
Acid-base balance, under physiological conditions, is
strictly controlled by the net endogenous acid production
related to acid and alkali dietary intake, and the incom-
plete metabolism of organic acids. The main dietary
source of alkali is the conjugate base of potassium salts
present in fruits and vegetables whereas the non dairy ani-
mal proteins, such as those present in meat, poultry, fish
and eggs, which contain amino acids with sulfur moieties,
represent the principal intake of dietary acid. 
The administration of alkaline-citrates (such as sodium-cit-
rate, potassium citrate, potassium-magnesium citrate,
especially potassium citrate) for the medical treatment of
stone-formers with hypocitraturia and prevention of stone
recurrence is recommended by most international guide-
lines. Prospective randomized trials exist regarding the
treatment of stone recurrence by means of alkali citrate
therapy lasting at least 1 year (3, 4). The results of these tri-
als seem to suggest that the correction of this metabolic
alteration using medical therapy reduces stone risk recur-
rence. Gastrointestinal side effects are quite common in
these patients (approximately 10%) with a consequent
decrease in compliance of up to 25% (16). The reduced
compliance is also due to other factors, such as cost. 
Vegetables
The relationship between a diet rich in vegetables and uri-
nary citrate excretion has also been examined. 
Increased intake of fruit and vegetables (excluding those
with high oxalate content) increases citrate excretion and
consequently decreases urinary saturation for calcium
oxalate and calcium phosphate. In fact hypocitraturic sub-
jects have a lower fruit intake (Domrongkitchaiporn et al.
2006, observational study L) (5) and an high consumption
of vegetables involves a significant protection against the
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risk of stone formation (Hess et al. 1994, observational study
L, Siener et al. 2005, observational non controlled study L,
Trinchieri A et al. 2006 and 2013, observational studies L,
Meschi et al. 2004, interventional study M) (6-10).
Citrus and non citrus juices
Several authors had studied the possible influence of the
consumption of fruit juices (both citrus and non citrus) on
urinary citrate excretion. Information on citrate concen-
trations in citrus juices, non citrus juices and commercial-
ly available citrus based beverages are now available
(Haleblian et al. 2008) (11).
Lemon juice
Drinking lemonade or freshly squeezed lemon juice sig-
nificantly raised urinary citrate levels at least twofold
(Seltzer 1996, interventional non controlled M; Aras et al.
interventional non randomized M; Kang observational L)
(12-14). A decrease in urinary calcium excretion and no
changes in urine oxalate levels were also observed. In
some studies, the authors were not able to find a sig-
nificant change in the urinary excretion induced by
lemon therapy (Koff, et al 2007 experimental non con-
trolled M) (15) or they found lower increases with
respect to potassium citrate or orange juice (Penniston et
al 2007 observational L, Odvina et al. experimental non
randomized M) (16, 17).
Orange juice
Orange juice consumption resulted in a significantly high-
er urinary citrate excretion when compared to lemonade.
On the contrary urinary oxalate was significantly higher
during orange juice consumption, a finding which was not
observed with the lemonade consumption. 
The saturation ratio of calcium oxalate tended to be lower
during orange juice consumption compared with lemon-
ade, but the difference was not significant. (Penniston et al.
2007 observational L: Wabner et al. 1993) (16, 18).
Grapefruit juice
Grapefruit juice significantly increased urinary citrate and
urinary oxalate levels. These events were not associated
with an increased risk of supra-saturation of calcium
oxalate, calcium phosphate or uric acid. In other words,
the increase in oxalate excretion, which would promote
lithogenicity, was offset by the increase in citrate excretion
(Goldfarb et al. 2001, experimental M) (19).
Lime juice
In renal stone formers a solution containing lime powder
significantly increased urine citrate, potassium, and pH
(Tosukhowong et al. 2008 experimental M) (20).
Non citrus juices
Cranberry juice had controversial effect on urine citrate
(no effect or increase of 31%), but resulted in a signifi-
cantly increased concentration of urinary calcium and
oxalate (Gettman et al. 2005 experimental non controlled M,
McHarg et al. 2003 experimental cross over M) (21, 22).
Unsweetened blackcurrant diluted juice increased urinary
citrate by 25% over baseline (Kessler et al. 2002 experimen-
tal M) (23). The consumption of a non citrus alkaline fruit
(melon) also has a positive effect in increasing citraturia as
compared to citrus fruit consumption (Baia et al. 2012
experimental M) (24).
Other drinks
In non stone-formers the citrus-based sport drink
Performance® increased citrate excretion and urine pH,
but the other sport drink Gatorade® did not change either
parameter significantly. Thus, Performance® appears to
have effects on urine citrate which are similar in magnitude
to those observed in some studies using homemade lemon-
ade (Goodman et al. 2009, experimental M) (25). 
Consumption of soda showed no significant variations of
citrate urinary excretion (Passman et al. 2009 experimen-
tal M) (26). Despite the efficacy of these different types of
drinks in raising urine citrate, practitioners must be cau-
tious in recommending high volumes of juices or sports
beverages for long-term citrate replacement, due to the
high caloric content of many preparations that might be
associated with unwanted carbohydrate consumption.
Conclusions
Several patients require modification of their dietary regi-
men instead of medical treatment as a first option for the
prevention of stone recurrence. Both citrus fruits (lemons,
oranges, grapefruit, and lime) and non citrus fruits
(melon) are natural sources of dietary citrate, and several
studies have shown the potential of these fruits and/or
their juices in raising urine citrate levels. Nevertheless,
future prospective randomized trials having hypocitraturia
dietary treatment as the primary endpoint and also com-
paring pharmacologic therapy with dietary interventions
are needed.
Dietary prevention in the child renal stone patient
Background
Nephrolithiasis in children is most prevalent between 3
and 5 years old, even if it can arise from early childhood
to late adolescence. It affects males more frequently than
females (1). The most frequent causes of nephrolithiasis in
children are urinary tract infections (up to 60% of cases in
some records), metabolic abnormalities (including idio-
pathic hypercalciuria), congenital urogenital malforma-
tions, and cystinuria (2-3). The most frequent composi-
tion of stones in children is calcium oxalate (45%), fol-
lowed by calcium phosphate (25%), struvite (17%) and
cystine (8%), while uric acid stones are very rare (4).
Metabolic abnormalities, like hypercalciuria and hypoci-
traturia, are less prevalent than in adults, although this dif-
ference attenuates in adolescents (4). More recent reports
however state that their prevalence is rising (5). A com-
plete metabolic evaluation of urinary risk factors is nowa-
days considered mandatory also in young children (6).
Hypercalciuria is traditionally considered the most impor-
tant urinary risk factor for lithogenesis in children (4, 7-
9), especially in recurrent patients (7). However, recent
reports state that hypocitraturia is nowadays the most
prevalent risk factor (8, 10) and probably the major
responsible for kidney stone formation in children (11). A
poor hydration is often another fundamental risk factor
(12-13). Urinary calcium excretion is generally higher in
stone forming children than in healthy age- and sex-
matched controls (14). In some cases, hypercalciuria may
be caused by excessive vitamin D intake for rickets pre-
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vention (15-16) or by genetic polymorphisms inducing an
abnormal vitamin D metabolism (17). 
Hyperoxaluria is the leading metabolic risk factor in about
20% of pediatric patients (4) and is often genetically-
determined (primary hyperoxaluria type 1 and 2),
although almost half of cases have a dietary origin (18).
The relationship between overweight/obesity and
nephrolithiasis in children is controversial, with some
studies reporting a higher prevalence of hyperoxaluria and
hypocitraturia in obese children (19) and others denying
any association between body mass index and urinary fac-
tors of lithogenic risk (20). There are also data stating that
underweight, rather than overweight, is a risk factor for
nephrolithiasis in children (21). 
Dietary treatment of hypercalciuria in children
1. Diets with a high calcium content (up to 1 g/day) are not
harmful for urinary calcium excretion, both in stone form-
ing and in control children. Therefore, dietary calcium
restriction is not recommended for children with
nephrolithiasis. A diet with 1 g of calcium per day induces
a significant (20%) rise in urinary calcium excretion last-
ing only 3 days in stone forming children, compared to a
calcium restriction (400 mg/day). After this period, urinary
calcium excretion returns to basal levels. Moreover, dietary
calcium restriction may promote urinary calcium excretion
by inducing a rise in calcitriol levels (22). Moreover, chil-
dren that are used to a low calcium intake are more sensi-
tive to variations in dietary calcium content (23). 
2. Moderate dietary salt restriction and implementation of
potassium intake are useful in limiting urinary calcium
excretion and thus for primary and secondary prevention
of nephrolithiasis. A direct correlation between urinary
sodium and urinary calcium excretion and an inverse cor-
relation between urinary potassium and calcium have
been demonstrated in children. These correlations are
even stronger in adolescents, who are probably more
prone to eat large amounts of salty foods and to avoid fruit
and vegetables (24). A study carried out on 11 children
with idiopathic hypercalciuria has demonstrated that
potassium supplementation, through fruit and vegetable
intake or potassium citrate ingestion, is associated to a
drop in urinary calcium and lithogenic risk (25). Another
study, carried out on a small sample of calcium stone for-
mers, found that a diet with a low salt (1-2 mg/kg/day)
and a high potassium intake (1 mEq/kg/day) is able to
treat hypercalciuria in virtually all patients (26). However,
another study from the same research group found that a
low-salt high-potassium protein-balanced diet is effective
in resolving hypercalciuria only in 33% of cases (27).
These results have been confirmed by a more recent study,
where the above mentioned diet proved to be effective in
treating hypercalciuria in only 24% of 46 hypercalciuric
children aged more than 4 (28). The largest study carried
out on dietary treatment of hypercalciuric pediatric calci-
um nephrolithiasis has instead showed that dietary salt
restriction alone (1-2 mg/kg/day) is effective in reducing
calcium excretion in 65 out of 131 (49,6%) subjects (29). 
3. The best therapeutical approach for treating hypercalci-
uria in children is to prescribe a 3-month period of low-
salt high-potassium diet, followed by personalized phar-
macological therapy if hypercalciuria does not resolve. 
Almost every study carried out on pediatric hypercalciuria
adopted this approach (a 3-month run-in period with
dietary therapy followed by a new metabolic evaluation
and pharmacologic therapy if metabolic abnormalities do
not resolve), which has proven to be very effective (27-
30). This sequential therapeutic schedule is also very effec-
tive in preventing kidney stone recurrences on a long-term
follow-up (30). The main limitation of these studies is the
fact that data are analyzed in an aggregate way, so that the
effects of dietary therapy alone are not discernible from
that of dietary therapy plus pharmacological intervention. 
Dietary treatment of hypocitraturia in children
4. Hypocitraturia in children is most likely due to a high
salt and sugar intake and to a consumption of fruit and
vegetables lower than recommended. Like in adult stone
formers, also in children salt and sugar intake is inversely
correlated with urinary citrate excretion (31). Moreover,
hypocitraturic children with kidney stones have low levels
of urinary phytate, which is a reliable marker of fruit and
vegetable consumption (32). In Western countries, it has
been demonstrated that children have an extremely low
average intake of vegetables, while the consumption of
fruit is slightly increasing in recent years, anyhow lower
than recommended (33-34).
5. No studies have assessed the effect of fruit and vegetable
supplementation and/or dietary salt and sugar restriction
on urinary citrate excretion in pediatric calcium stone for-
mers so far. Therefore, at the moment there is no scientific
evidence to recommend this dietary intervention in
hypocitraturic children. Even in those studies who have
evaluated the possible therapies for pediatric nephrolithi-
asis in a combined way, hypocitraturia was always treated
with pharmacological supplementation with potassium
citrate (27, 30). This treatment has however proven effec-
tive both in raising urinary citrate levels and in diminish-
ing recurrence rates (35).
6. Despite the lack of specific studies, given the well-
known benefits of fruit and vegetable intake, it seems rea-
sonable to advice a balanced consumption of these foods,
according to general nutritional guidelines. 
Dietary treatment of hyperoxaluria in children
7. Apart from genetic hyperoxaluria, a high urinary oxalate
excretion in children and adolescents is most likely due to
a high consuption of oxalate-rich foods such as chocolate
and cola. A dietary load of chocolate is able to cause tran-
sient hyperoxaluria in adults (36-37). The habitual con-
sumption of cola has also been linked to hyperoxaluria
(38). Intake of other oxalate-rich foods does not automat-
ically result in hyperoxaluria, due to lower bioavalaibility
(39). It has been demonstrated that children and adoles-
cents have significantly higher intake of chocolate and cola
than adults (40-42). 
8. No studies have assessed the effects of chocolate and
cola restriction on hyperoxaluric pediatric stone formers
so far. Therefore, at the moment there is no scientific evi-
dence to recommend this dietary intervention in hyperox-
aluric children. All studies that have considered hyperox-
aluric pediatric patients have tested dietary interventions
combined with pharmacologic approach (vitamin B6),
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demonstrating that this therapy is effective in reducing
hyperoxaluria and preventing stone recurrences (24,30).
9. Despite the lack of specific studies, given the well-
known benefits of limiting cola and chocolate intake, it
seems reasonable to advice a low consumption of these
foods, according to general nutritional guidelines.
Importance of urinary volume in children
10. There are no studies assessing the effectiveness of
water therapy alone in the prevention of kidney stone
recurrences in pediatric patients. However, given the
availability and strength of data in adults, there are suffi-
cient basis to advice an adequate fluid intake also in chil-
dren. In adults, water therapy alone, as to maintain uri-
nary volume over 2 litres per day, is able to prevent 44%
of recurrences in patients with a first episode of renal colic
(43). No data are available for children, but all studies car-
ried out on pediatric nephrolithiasis have prescribed an
adequate fluid intake in addition to dietary and pharma-
cological treatments. These recommendation may be cru-
cial in pediatric subjects where no metabolic abnormalities
are present (12-13). 
Diet for the obese children with kidney stones
11. No studies have assessed specific dietary treatments to
prevent nephrolithiasis in obese children. Therefore, in
this category of patients, it seems reasonable to recom-
mend the usual diets for childhood obesity. 
Dietary treatment in children with cystinuria
12. Despite the low level of scientific evidence, a low-pro-
tein (< 20 g/day) low-salt (< 2 g/day) diet with high hydra-
tion (> 3 litres/day) is strongly advised in children with
cystinuria.In a study carried out on one patient with
cystinuria many years ago, a 20 g/day protein intake
proved to reduce basal cysteine levels by 31% compared
with a 117 g/day protein intake (44). It is probable that
cystine excretion is strongly influenced also by the specific
type of proteins of foods. A diet with a high glutamine but
with normal overall protein intake is actually able to
diminish cystine excretion (45). However, this dietary
manipulation is effective only when salt intake is liberal
(46). Salt restriction itself is highly effective in diminishing
cystine excretion, provided that it is very strict (< 2 g/day)
(46-47). In a study carried out on 5 patients, a salt intake
< 2 g/day has been associated to a 50% reduction in urinary
cystine (47). However, such a strict salt restriction is very
difficult to achieve and maintain in Western countries. 
Dietary therapy in cystinuria has only a supportive role
13. Low-protein low-salt high-fluid diet alone is poorly
effective in preventing kidney stone recurrences in cystin-
uria. Association with urinary alkalinization and pharma-
cological treatment with thiola is often mandatory to
achieve an acceptable prevention (48). 
Final considerations and conclusions
High- or fair-quality intervention studies on dietary treat-
ment of pediatric nephrolithiasis are lacking. Available
studies have in fact several important limitations, includ-
ing: Low number of patients; Poor characterization of the
precise diagnosis of patients (i.e., idiopathic calcium
nephrolithiasis vs secondary calcium nephrolithiasis vs
asymptomatic crystalluria); Poor characterization of meta-
bolic phenotype; No stratification of data and results for
metabolic phenotype; Multiple treatments (dietary inter-
ventions are often studied together with drug therapy);
Lack of stratification for age groups (some studies consid-
er together patients younger than 2 years old and adoles-
cents); Poor characterization of basal dietary habits; Poor
definition of outcomes; Short term follow-ups. 
Moreover, some of these studies were carried out many
years ago, and thus did not take into account epidemio-
logic changes that occurred in the last decade(s). 
Therefore, it is not possible to express any high- or fair-
level recommendation on dietary therapy in pediatric
nephrolithiasis. All advices reported above are thus relying
on poor-quality data or on expert opinion. 
Dietary prevention in the elderly renal stone patient 
Background
Definition of elderly patient: The chronological age of 65
years as a definition of 'elderly' patient has conventionally
been accepted. However, this convention is not exhaustive
and is rather restrictive, not taking into account the large
inter-individual biological variability within the same
chronological age. Therefore it would be more appropriate
to take into consideration some parameters referring to
biological aging, as regressive change of the structure and
the function of different organs and systems of the human
body. The elderly, however defined, has a lower function-
al reserve and increased fragility compared to the young
(1-2). Therefore during the biological process of aging
changes of the body occur that affect clinical and diagnos-
tic aspect in the elderly.
Epidemiology of nephrolithiasis in the elderly: In the case
series reported by various studies on nephrolithiasis, 10-
12% (3-4) of the patients with urinary stones are over 65
years. However, in the general population over the age of
65, it has been shown a ratio of stone formation ranging
0.1-2%, that is not higher compared to that found in the
younger population (5-6). An increase of crystalluria,
which is known to represent a potential early stage of lithi-
asis, has also been described in the urine of elderly sub-
jects (7). In the elderly recurrence and severity of the stone
disease is the same than in the general population (4).
Stone composition and metabolic aspects of nephrolithiasis
in the elderly: Before dealing with the presence of meta-
bolic risk factors for stone formation in the elderly popu-
lation, it has to be pointed out that the average level of
renal function in the elderly is reduced compared to
younger patients. This aspect by itself may contribute to
metabolic changes in the older patient with nephrolithia-
sis. For example, it is known that there is a reduction of
calcium excretion in relation to the decrease of glomerular
filtration and associated to a reduced intestinal absorption
of this mineral. Well-known alterations of bone metabo-
lism and intermediary metabolism can influence both
some typical parameters of mineral metabolism (PTH, cal-
cium, phosphorus) and of intermediary metabolism (uric
acid).Moreover, it has to be pointed out that the style of
life, in particular for what concerns the food habits, is
changed significantly with increasing age. 
Accordingly, the larger series show that calcium oxalate
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stones are the more frequent also in elderly patients as in
the general population but the rate of uric acid stones is
greater in the elderly (4, 8, 9). Some studies show that
about 10-20% of patients suffering from gout form uric
acid stones and conversely that 40% of patients with uric
acid stones develop gout (10, 11). About 50% of elderly
people suffering from kidney stones show an isolated
metabolic defect in 24 hour urine (12). The most frequent
is hypocitraturia with a rate in stone patients from 29% to
56% (4, 13). This figure would seem correlated to a phys-
iological metabolic acidosis related to the progressive
decrease of renal function with age. A urine pH below 5.5
promotes uric acid stone formation more than hyperuri-
cosuria or hyperuricemia (10). In elderly people suffering
from kidney stones, the values of PTH are significantly
increased and the values of 1,25-hydroxyvitamin D
reduced (4). Furthermore, especially in the elderly
patients on long-term care, lower levels of natural vitamin
D were found (14, 15). Metabolic abnormalities are equal-
ly represented in both sexes in the elderly. In addition to
the different prevalence of some metabolic disorders, other
factors that are potentially lithogenic, could contribute to
renal stone formation in the elderly. Among these factors,
infections of the urinary tract and reduced mobility could
play a major role. In fact infections of the urinary tract are
common in the elderly. However, although some studies
show that in the elderly there is an increased risk of uri-
nary tract infection, such data are not correlated to an
higher rate of infection stones, that account for only 1% in
the elderly (4-8). The reduction of ambulation in the eld-
erly could cause an increased excretion of calcium in the
urine. However, this condition is described only after pro-
longed periods of immobilization. 
Diet 
Dietary counseling for renal stone prevention in the elder-
ly has to consider some particular aspects of aging.
1. About sodium intake, it is well known that diets high in
sodium expose renal stone patients, especially if over-
weight and hypercalciuric, to an increase in urinary calci-
um excretion (Taylor 2006 prospective study, evidence L)
(16) which may increase the lithogenic risk and the risk to
develop hypertension and bone demineralization. 
However, it should be considered that the elderly patient is
particularly sensitive to sodium intake from a hemody-
namic point of view. Consequently, effects of any other
concomitant therapy have to be attentively considered in
relation to this aspect.
2. It is also known that a diet with a higher content of
potassium, magnesium and citrate, is particularly effective
not only in reducing the incidence of urinary risk factors
for stone formation (hypercalciuria, hypocitraturia) but
also in preventing the loss of bone mass and the incidence
of arterial hypertension (Ettinger 1997 prospective study,
evidence L) (17). There are no particular additional prob-
lems in recommending such a diet in the older patient.
3. An important aspect to be considered is the calcium con-
tent in the diet. In the past, patients with calcium
nephrolithiasis were given advice to avoid foods with an
high calcium content. In recent decades more data have
accumulated showing that a diet with a normal calcium
content, but with reduced intake of animal protein (Taylor,
2009, prospective, evidence L) (18) would be more protective
on the lithogenic risk compared to a diet with reduced
intake of calcium and oxalate, in particular in subjects with
hypercalciuria. In fact, the reduced availability of calcium
in the intestine would favor the increase of intestinal
absorption of oxalate (Messa, 1997 prospective study, evi-
dence L) (19). Moreover, a low-calcium diet expose patients
to an increased risk of osteoporosis. This risk is certainly
higher in the elderly, especially if female. There is no gen-
eral indication in the renal stone patient to a low-calcium
diet and even less in the elderly. Therefore a diet rich in cal-
cium (1200 mg/day) would be useful for the proper main-
tenance of both the musculoskeletal wellness and the pre-
vention of kidney stones. In contrast a further supplemen-
tation could involve an increase of risk for both the forma-
tion of kidney stones and cardiovascular diseases (20).
4. Diets high in animal protein have been recognized to
increase the risk of stone formation, probably by increas-
ing the acid load (which reduces the excretion of citrate
and rises calcium excretion secondary to increased
removal from the bone) and the production and excretion
of uric acid. Although there are no prospective random-
ized studies that provide clear evidence of its clinical
effects on prevention of renal stone disease and hyperten-
sion, some observational studies suggest that the adoption
of a low-sodium diet, with increased intake of fruits and
vegetables and reduced fat intake can be effective in the
prevention of nephrolithiasis (Taylor, 2009, prospective,
evidence L) (18). In any case, a diet with lower content of
animal protein and higher intake of plant products has no
particular contraindications in the elderly patient with
nephrolithiasis, although overall nutritional status of such
patients must be always evaluated with great attention.
5. The available information about the usefulness of the
reduction in the content of dietary oxalate is poor (Taylor,
2007, prospective, evidence L) (21). Therefore, in the elder-
ly, it remains a questionable. 
In renal stone patients with high disease activity, when
diet is not effective, use of drugs and dietary supplements
(thiazide diuretics, allopurinol, citrate salts, etc.) is often
advisable. There are no differences in prescribing pharma-
cological treatment in the elderly with respect to younger
renal stone patients, although greater caution should be
maintained in the use of diuretics (Sonnenblick, 1993 obser-
vational study, evidence L) (22) for the obvious hemody-
namic reasons and the greater frequency of decreased
renal function in this range of age. In the case of elderly
patients with nephrolithiasis on therapy with inhibitors of
the renin-angiotensin-aldosterone system, attention
should also be taken in the use of potassium citrate salts.
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